508 related articles for article (PubMed ID: 19491186)
1. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U
JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186
[TBL] [Abstract][Full Text] [Related]
2. Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Umaña J; Tate J; Lopman B; Sanchez E; Reyes M; Mercado J; Gonzalez A; Perez MC; Balmaceda A; Andrus J; Parashar U
Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2012 Nov; 11():CD008521. PubMed ID: 23152260
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684685
[TBL] [Abstract][Full Text] [Related]
8. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008521. PubMed ID: 30912133
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.
Cardellino A; Khawaja S; Sánchez Cruz E; Mast TC
Hum Vaccin Immunother; 2013 Jul; 9(7):1449-53. PubMed ID: 23571175
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of monovalent and pentavalent rotavirus vaccine.
Cortese MM; Immergluck LC; Held M; Jain S; Chan T; Grizas AP; Khizer S; Barrett C; Quaye O; Mijatovic-Rustempasic S; Gautam R; Bowen MD; Moore J; Tate JE; Parashar UD; Vázquez M
Pediatrics; 2013 Jul; 132(1):e25-33. PubMed ID: 23776114
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2012 Feb; (2):CD008521. PubMed ID: 22336845
[TBL] [Abstract][Full Text] [Related]
14. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Cortese MM; Parashar UD;
MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
[TBL] [Abstract][Full Text] [Related]
17. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
[TBL] [Abstract][Full Text] [Related]
18. Hospital-based surveillance and analysis of genotype variation in Nicaragua after the introduction of the pentavalent rotavirus vaccine.
Khawaja S; Cardellino A; Mast TC
Pediatr Infect Dis J; 2014 Jan; 33(1):e25-8. PubMed ID: 24042492
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
